NVIDIA
NVDA
Cisco
CSCO
ASML Holding
ASML
4
Taiwan Semiconductor
TSM
5
Disney
DIS
US Stock MarketDetailed Quotes
INCY Incyte
- 60.710
- +0.030+0.05%
Trading Mar 28 14:11 ET
11.75BMarket Cap404.73P/E (TTM)
60.970High60.350Low362.38KVolume60.720Open60.680Pre Close21.97MTurnover0.23%Turnover Ratio404.73P/E (Static)193.52MShares83.95052wk High3.41P/B9.80BFloat Cap50.35052wk Low--Dividend TTM161.34MShs Float153.150Historical High--Div YieldTTM1.02%Amplitude1.850Historical Low60.627Avg Price1Lot Size
Incyte Stock Forum
Sign in to post a comment
Columns Wall Street Today: DJIA, S&P 500 and Nasdaq Composite All End in the Green on St. Patrick's Day
The Dow Jones Industrial Average, S&P 500 and Nasdaq Composite all ended in the green Monday for St. Patrick's Day, rising for a second straight session as markets continued to partially rebound from their recent tariff-induced sell-off.
The $Dow Jones Industrial Average (.DJI.US)$ led the way higher, gaining 353.45 points (0.9%) to end the day at 41.841.63. The $S&P 500 Index (.SPX.US)$ likewise added 3...
The $Dow Jones Industrial Average (.DJI.US)$ led the way higher, gaining 353.45 points (0.9%) to end the day at 41.841.63. The $S&P 500 Index (.SPX.US)$ likewise added 3...
26
1
5
$Incyte (INCY.US)$
Breakthrough: Dual Phase 3 Trials Prove Povorcitinib's Success in Treating Hidradenitis Suppurativa
Breakthrough: Dual Phase 3 Trials Prove Povorcitinib's Success in Treating Hidradenitis Suppurativa
$Incyte (INCY.US)$
Can Incyte's Opzelura Break Through in Prurigo Nodularis? Phase 3 Data Reveals Critical Insights
Can Incyte's Opzelura Break Through in Prurigo Nodularis? Phase 3 Data Reveals Critical Insights
$Incyte (INCY.US)$
Can Incyte's New Clinical Data Revolutionize Prurigo Nodularis Treatment? AAD 2025 Reveals Answers
Can Incyte's New Clinical Data Revolutionize Prurigo Nodularis Treatment? AAD 2025 Reveals Answers
$Incyte (INCY.US)$
AI Meets Drug Discovery: Inside Incyte's $620M Genesis Deal - Will This Transform Pharma R&D?
AI Meets Drug Discovery: Inside Incyte's $620M Genesis Deal - Will This Transform Pharma R&D?
$Incyte (INCY.US)$ $Agenus (AGEN.US)$ Reuters· 2 mins ago
Agenus Inc - Incyte to Terminate Agreement With Agenus Effective February 2026
Agenus Inc - Incyte to Terminate Agreement With Agenus Effective February 2026
$Merck & Co (MRK.US)$ $Incyte (INCY.US)$ is a great company. Buying it would be a good decision, unless Merck massively overpays.
3
Click Here: TYNKR LAB™
U.S. stock markets closed with mixed results, reflecting cautious investor sentiment as major tech earnings approached alongside key economic data. $Dow Jones Industrial Average (.DJI.US)$ fell by 0.36%, while $S&P 500 Index (.SPX.US)$ and $Nasdaq Composite Index (.IXIC.US)$ posted gains of 0.16% and 0.81%, respectively. This divergence highlights sector-specific movements and investor positioning ahead ...
U.S. stock markets closed with mixed results, reflecting cautious investor sentiment as major tech earnings approached alongside key economic data. $Dow Jones Industrial Average (.DJI.US)$ fell by 0.36%, while $S&P 500 Index (.SPX.US)$ and $Nasdaq Composite Index (.IXIC.US)$ posted gains of 0.16% and 0.81%, respectively. This divergence highlights sector-specific movements and investor positioning ahead ...
+2
2
2
🚨 This Week’s PDUFAs:
$Regeneron Pharmaceuticals (REGN.US)$ : 🤔
⇨ Linvoseltamab
‣ Multiple myeloma
‣ PDUFA: 8/22/24 (BLA)
🗓️ Last Week’s PDUFAs:
$Gilead Sciences (GILD.US)$ : Approved 8/14 🎉
⇨ Livdelzi (Seladelpar)
‣ Primary biliary cholangitis (PBC)
‣ PDUFA: 8/14/24 (NDA)
$Ascendis Pharma A/S (ASND.US)$ : Approved 8/12 🎉
⇨ YORVIPATH (palopegteriparatide)
‣ Hypoparathyroidism
‣ PDUFA: 8/14/24 (NDA)
$Syndax Pharmaceuticals (SNDX.US)$ & $Incyte (INCY.US)$ : Approved 8/14 🎉
⇨ Nikt...
$Regeneron Pharmaceuticals (REGN.US)$ : 🤔
⇨ Linvoseltamab
‣ Multiple myeloma
‣ PDUFA: 8/22/24 (BLA)
🗓️ Last Week’s PDUFAs:
$Gilead Sciences (GILD.US)$ : Approved 8/14 🎉
⇨ Livdelzi (Seladelpar)
‣ Primary biliary cholangitis (PBC)
‣ PDUFA: 8/14/24 (NDA)
$Ascendis Pharma A/S (ASND.US)$ : Approved 8/12 🎉
⇨ YORVIPATH (palopegteriparatide)
‣ Hypoparathyroidism
‣ PDUFA: 8/14/24 (NDA)
$Syndax Pharmaceuticals (SNDX.US)$ & $Incyte (INCY.US)$ : Approved 8/14 🎉
⇨ Nikt...
8
No comment yet
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
Chak : louda tarriff , mad har chod powell cut down the interesr rate